Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

I think it's clear something material is going on. Whether it's a deal or buyout or something else is yet to be seen. But if those 5 execs are truly no longer there, that would imply the company may no longer plan to stay independent as those are core positions. The most negative scenario, which I don't think is the case, is that they finally realize after being forced to do a dilution on worst ever terms, that investors want them to reduce headcount and they are aggressively doing that now. However, I don't see them cutting the head of regulatory affairs now in a clincial hold unless there is some other person or entity assuming that responsibility.